论文部分内容阅读
体外反搏是目前国内外治泞冠心病心绞痛的一种无创伤性治疗措施,它在冠心病和脑供血不足等缺血性疾病的治疗中,已取得了较好的疗效。主要由于它能显著地提高主动脉舒张压,增加冠脉血流灌注量,促进冠脉侧支循环的形成及开放,因而为冠心病心绞痛治疗开创了一条新的途径。现将我院1986年3月以来开展体外反搏治疗冠心病14例的疗效观察报告如下。临床资料一、病例选择本组14例冠心病患者均符合1974年冠心病诊断参考标准,因反搏前曾服用扩冠等
Extracorporeal counterpulsation is currently a noninvasive treatment of angina pectoris at home and abroad, it has achieved good results in the treatment of ischemic diseases such as coronary heart disease and cerebral insufficiency. Mainly because it can significantly improve aortic diastolic blood pressure, increase coronary perfusion, and promote the formation and opening of coronary collateral circulation, which opened up a new way for the treatment of angina pectoris. Now in our hospital since March 1986 to carry out in vitro ECP in the treatment of coronary heart disease in 14 cases reported the following observations. Clinical data A case selection The group of 14 patients with coronary heart disease are in line with the 1974 diagnosis of coronary heart disease reference standards,